NCT07630129

Brief Summary

This study is to prospectively assess the feasibility and clinical implications of intraoperative real-time cAR monitoring using the Medtronic Cotrending algorithm.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
256

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Dec 2025Dec 2026

Study Start

First participant enrolled

December 17, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 29, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 5, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

June 5, 2026

Status Verified

June 1, 2026

Enrollment Period

1 month

First QC Date

May 21, 2026

Last Update Submit

June 1, 2026

Conditions

Keywords

Noncardiac surgeryCerebral autoregulation (cAR)Cerebral Oximetry Index (COx)Cerebral lower limit of autoregulation (cLLA)Blood pressure (BP)Medtronic Cotrending algorithm

Outcome Measures

Primary Outcomes (1)

  • Technical feasibility of using the Medtronic Cotrending algorithm

    Specifically, it will be determined: * Success rate of cerebral lower limit of autoregulation (cLLA) determination: proportion of patients in study cohort in whom cerebral autoregulatory parameters could be determined * Intraoperative uptime: percentage of intraoperative time during which presumed valid and actionable estimates of cerebral autoregulatory parameters were delivered * Time to first estimate of cerebral autoregulatory parameters: Elapsed intraoperative time to first presumed valid estimates of cerebral autoregulatory parameters * Sensitivity to external factors: Sensitivity of the algorithm to known confounders and determinants of cerebral autoregulatory function, e.g. changes in gas exchange, administration of vasopressors, skin pigmentation. * Sensitivity to data artefacts: Sensitivity of the algorithm to artefacts in data (e.g. in BP or rSO2 signals).

    one time assessment at study end

Other Outcomes (6)

  • Between-patient variability in the intraoperative Cotrending-derived boundaries of cerebral autoregulation

    one time assessment at study end

  • Within-patient variability in the intraoperative Cotrending-derived boundaries of cerebral autoregulation

    one time assessment at study end

  • Predictability of intraoperative Cotrending-derived boundaries of cerebral autoregulation

    one time assessment at study end

  • +3 more other outcomes

Interventions

Data collection from a subset of patients from AUTOREGULATE-NONCARDIAC study (ClinicalTrials.gov NCT05336864) who underwent intraoperative cerebral oximetry monitoring with the Medtronic INVOSTM near-infrared spectroscopy (NIRS) device. Analysis of data will be offline, i.e. following conclusion of surgery.

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The substudy data originate from AUTOREGULATE-NONCARDIAC (NCT05336864) and will encompass all patients monitored intraoperatively with the Medtronic INVOS(TM) NIRS device, i.e. all patients included at the University Hospital Basel study center. The substudy population demographics are representative of the AUTOREGULATE-NONCARDIAC study population.

You may qualify if:

  • All patients included in AUTOREGULATE-NONCARDIAC at the University Hospital Basel study center with the Medtronic INVOS(TM) near-infrared spectroscopy (NIRS) device.

You may not qualify if:

  • No intraoperative data collected

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel

Basel, 4031, Switzerland

Location

MeSH Terms

Interventions

Data Collection

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Patrick M. Wanner

    Clinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2026

First Posted

June 5, 2026

Study Start

December 17, 2025

Primary Completion

January 29, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

June 5, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations